Surveillance of Community-based Reservoirs Reveals the Presence of CTX-M, Imported AmpC, and OXA-30 Beta-lactamases in Urine Isolates of Klebsiella Pneumoniae and Escherichia Coli in a U.S. Community

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 2008 Jul 30

PMID 18663030

Citations 18

Authors

Nancy D Hanson

Ellen Smith Moland

S G Hong

Katie Propst

Deborah J Novak

Stephen J Cavalieri

Affiliations

Soon will be listed here.

Abstract

beta-Lactamases produced by urine isolates from patients in long-term care facilities (LTCFs), outpatient, clinics, and one hospital in a U.S. community were characterized. A total of 1.3% of all Escherichia coli and Klebsiella pneumoniae isolates collected from patients in 30 LTCFs and various outpatient clinics produced extended-spectrum beta-lactamases (ESBLs) and/or imported AmpC beta-lactamases.

Citing Articles

Prevalence of plasmid-mediated AmpC beta-lactamases in Enterobacteria isolated from urban and rural folks in Uganda.

Najjuka C, Kateete D, Lodiongo D, Mambo O, Mocktar C, Kayondo W AAS Open Res. 2021; 3:62.

PMID: 34549164 PMC: 8422338. DOI: 10.12688/aasopenres.13165.1.

American Crows as Carriers of Extra Intestinal Pathogenic and Avian Pathogenic-Like and Their Potential Impact on a Constructed Wetland.

Sen K, Shepherd V, Berglund T, Quintana A, Puim S, Tadmori R Microorganisms. 2020; 8(10).

PMID: 33081240 PMC: 7602749. DOI: 10.3390/microorganisms8101595.

Extended spectrum beta-lactamase and fluoroquinolone resistance genes among Escherichia coli and Salmonella isolates from children with diarrhea, Burkina Faso.

Dembele R, Konate A, Traore O, Kabore W, Soulama I, Kagambega A BMC Pediatr. 2020; 20(1):459.

PMID: 33010801 PMC: 7532561. DOI: 10.1186/s12887-020-02342-z.

The Antimicrobial Susceptibility of Klebsiella pneumoniae from Community Settings in Taiwan, a Trend Analysis.

Lin W, Wang J, Chang S, Chang F, Fung C, Chuang Y Sci Rep. 2016; 6:36280.

PMID: 27824151 PMC: 5099973. DOI: 10.1038/srep36280.

Antimicrobial susceptibility profiles of Escherichia coli and Klebsiella pneumoniae isolated from outpatients in urban and rural districts of Uganda.

Najjuka C, Kateete D, Kajumbula H, Joloba M, Essack S BMC Res Notes. 2016; 9:235.

PMID: 27113038 PMC: 4843195. DOI: 10.1186/s13104-016-2049-8.

References

Pitout J, Hanson N, Church D, Laupland K . Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes. Clin Infect Dis. 2004; 38(12):1736-41. DOI: 10.1086/421094. View

Bradford P, Bratu S, Urban C, Visalli M, Mariano N, Landman D . Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin Infect Dis. 2004; 39(1):55-60. DOI: 10.1086/421495. View

Sanders C, Sanders Jr W, Moland E . Characterization of beta-lactamases in situ on polyacrylamide gels. Antimicrob Agents Chemother. 1986; 30(6):951-2. PMC: 180628. DOI: 10.1128/AAC.30.6.951. View

Hanson N, Moland E, Hossain A, Neville S, Gosbell I, Thomson K . Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 beta-lactamases. J Antimicrob Chemother. 2002; 49(6):1011-4. DOI: 10.1093/jac/dkf052. View

Black J, Moland E, Thomson K . AmpC disk test for detection of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal AmpC beta-lactamases. J Clin Microbiol. 2005; 43(7):3110-3. PMC: 1169113. DOI: 10.1128/JCM.43.7.3110-3113.2005. View

Paterson D, Bonomo R . Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005; 18(4):657-86. PMC: 1265908. DOI: 10.1128/CMR.18.4.657-686.2005. View

Bonomo R, Donskey C, Blumer J, Hujer A, Hoyenm C, Jacobs M . Cefotaxime-resistant bacteria colonizing older people admitted to an acute care hospital. J Am Geriatr Soc. 2003; 51(4):519-22. PMC: 3419475. DOI: 10.1046/j.1532-5415.2003.51161.x. View

Pitout J, Hossain A, Hanson N . Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp. J Clin Microbiol. 2004; 42(12):5715-21. PMC: 535227. DOI: 10.1128/JCM.42.12.5715-5721.2004. View

Rankin S, Aceto H, Cassidy J, Holt J, Young S, Love B . Molecular characterization of cephalosporin-resistant Salmonella enterica serotype Newport isolates from animals in Pennsylvania. J Clin Microbiol. 2002; 40(12):4679-84. PMC: 154621. DOI: 10.1128/JCM.40.12.4679-4684.2002. View

10.

Pitout J, Gregson D, Church D, Laupland K . Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary. Emerg Infect Dis. 2007; 13(3):443-8. PMC: 2725889. DOI: 10.3201/eid1303.060447. View

11.

Lewis 2nd J, Herrera M, Wickes B, Patterson J, Jorgensen J . First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob Agents Chemother. 2007; 51(11):4015-21. PMC: 2151438. DOI: 10.1128/AAC.00576-07. View

12.

Crnich C, Safdar N, Robinson J, Zimmerman D . Longitudinal trends in antibiotic resistance in US nursing homes, 2000-2004. Infect Control Hosp Epidemiol. 2007; 28(8):1006-8. DOI: 10.1086/518750. View

13.

Oteo J, Navarro C, Cercenado E, Delgado-Iribarren A, Wilhelmi I, Orden B . Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J Clin Microbiol. 2006; 44(7):2359-66. PMC: 1489527. DOI: 10.1128/JCM.00447-06. View

14.

Dubois V, Arpin C, Quentin C, Texier-Maugein J, Poirel L, Nordmann P . Decreased susceptibility to cefepime in a clinical strain of Escherichia coli related to plasmid- and integron-encoded OXA-30 beta-lactamase. Antimicrob Agents Chemother. 2003; 47(7):2380-1. PMC: 161840. DOI: 10.1128/AAC.47.7.2380-2381.2003. View

15.

Canton R, Coque T, Baquero F . Multi-resistant Gram-negative bacilli: from epidemics to endemics. Curr Opin Infect Dis. 2003; 16(4):315-25. DOI: 10.1097/00001432-200308000-00003. View

16.

Wiener J, Quinn J, Bradford P, Goering R, Nathan C, Bush K . Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA. 1999; 281(6):517-23. DOI: 10.1001/jama.281.6.517. View

17.

Pitout J, Nordmann P, Laupland K, Poirel L . Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother. 2005; 56(1):52-9. DOI: 10.1093/jac/dki166. View

18.

Calbo E, Romani V, Xercavins M, Gomez L, Vidal C, Quintana S . Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J Antimicrob Chemother. 2006; 57(4):780-3. DOI: 10.1093/jac/dkl035. View

19.

Bradford P . Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001; 14(4):933-51, table of contents. PMC: 89009. DOI: 10.1128/CMR.14.4.933-951.2001. View

20.

Bradford P, Urban C, Jaiswal A, Mariano N, Rasmussen B, Projan S . SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. Antimicrob Agents Chemother. 1995; 39(4):899-905. PMC: 162650. DOI: 10.1128/AAC.39.4.899. View